Originally posted by Malo
Nearly 12 month's ago 13/12, the 80m shares man - Dixon, said they were looking at pre-filled syringes and other devices with improved margins. Now he says they are looking at 2 preclinical possibilities - absolutely meaningless stalling. It appears the matter I raised earlier about ownership is correct.
You still going on? about things you could email Dixon about or easier to have a whinge?
His email is conveniently on bottom of that ann.
You're obviously not keen to seek any answers.
"
the 80m shares man
" - you mean options to
convert at 10 and 20c.
I'd call that amazing incentive compared to many other options I see getting handed out.
